申请人:ESTEVE PHARMACEUTICALS, S.A.
公开号:US20200207759A1
公开(公告)日:2020-07-02
The present invention relates to new compounds of general formula (I) that show dual activity towards α2δ subunit of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit, and to the noradrenallne transporter (NET). The invention is also related to the process for the preparation of said compounds as well as to compositions comprising them, and to their use as medicaments.